secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0001213900-24-022451
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma amends bylaws to reduce shareholder quorum to 33-1/3%
--------------------------------------------------------------------

- Board approved amendment to Section 2.8 of Bylaws on March 14, 2024.
- Quorum requirement lowered from a majority to 33-1/3% of votes entitled to be cast.
- Amendment effective immediately as of March 14, 2024.
- Exhibit 3.2 (Amendment to Bylaws) filed with the SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024022451/0001213900-24-022451-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024022451/ea0201809-8k_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-022451

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer